A systematic review and meta-analysis of conventional laparoscopic sacrocolpopexy versus robot-assisted laparoscopic sacrocolpopexy

Pan, Ke; Zhang, Yao; Wang, Yanzhou; Wang, Yunle; Xu, Huilin

doi:10.1016/j.ijgo.2015.08.008

Cited by 76 publications

(28 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…From meta‐analyses of the two small randomised studies (totalling 156 patients) and several non‐randomised studies, the literature suggests that sacrocolpopexy performed via RS is associated with greater post‐operative pain and greater cost, with no significant differences in anatomical outcomes, pelvic floor function, quality of life or peri‐operative adverse events . It is speculated that there is a shorter learning curve for robotic‐assisted sacrocolpopexy, but this has not been proven in randomised trials …”

Section: Sacrocolpopexymentioning

confidence: 99%

The future of robotic‐assisted laparoscopic gynaecologic surgery in Australia – A time and a place for everything

Nicklin

2017

Aust NZ J Obst Gynaeco

View full text Add to dashboard Cite

There has been a significant increase in minimally invasive surgery in gynaecology over the last 15 years, with approximately only one-third of hysterectomies for benign disease now performed via laparotomy. While robotic surgery offers considerable technical advantages over conventional laparoscopy and is associated with only a modest learning curve, the improvement in clinical outcomes is marginal and there are several disadvantages. There are increased set-up and operating times, the need to accommodate and maintain large sophisticated equipment, and the requirement for additional training. The preeminent issue regarding the place of robotic gynaecological surgery is cost. How this is addressed and contained will ultimately determine uptake in Australia. From the published literature to date, robotic surgery compared with conventional laparoscopic surgery is associated with marginal improvements in clinical outcomes for benign hysterectomy and endometrial cancer surgery, but little improvement for other benign gynaecological surgery or for cervical cancer surgery. Robotic surgery probably does improve clinical outcomes in obese and morbidly obese patients and is associated with improved ergonomics for the surgeon. It is likely that there will be continued substantial improvements in robotic surgical platforms into the foreseeable future and that robotic surgery will play an increasingly important role in gynaecological surgery in Australia.

show abstract

Section: Sacrocolpopexymentioning

confidence: 99%

The future of robotic‐assisted laparoscopic gynaecologic surgery in Australia – A time and a place for everything

Nicklin

2017

Aust NZ J Obst Gynaeco

View full text Add to dashboard Cite

show abstract

“…The transfusion rate after abdominal sacrocolpopexy has been reported as 2.1% and from 0.5-0.8% after minimally invasive sacrocolpopexy. 12,18,19 A multicenter randomized control trial reported rates of transfusion of 3.7% and 2.2% for uterosacral ligament suspension and sacrospinous ligament fixation, respectively. 13 We found the transfusion rate to be 1.05% for procedures done for prolapse only, reflecting a combination of open, vaginal, and minimally invasive approaches.…”

Section: Commentmentioning

confidence: 99%

The incidence of transfusion and associated risk factors in pelvic reconstructive surgery

Pandya

Lynch

Hundley

et al. 2017

American Journal of Obstetrics and Gynecology

View full text Add to dashboard Cite

Transfusion after pelvic reconstructive surgery is uncommon. The variables associated with transfusion are preoperative hematocrit <30%, American Society of Anesthesiologists class, bleeding disorders, nonwhite race, Hispanic ethnicity, and concomitant hysterectomy. Recognition of these factors can help guide preoperative counseling regarding transfusion risk after pelvic reconstructive surgery and individualize preoperative preparation.

show abstract

“…Recurrance rates ranges from 0 to 14%. At the last year in our centre this procedure is the main option for rectal prolapse treatment [10,11].…”

Section: Discussionmentioning

confidence: 99%

Tiesiosios žarnos iškritimo chirurginis gydymas – vieno centro patirtis

Danys¹,

Kavaliauskaitė²,

Žalimas³

et al. 2016

View full text Add to dashboard Cite

BackgroundNo consensus on the optimal procedure for repair of rectal prolapse (RP) exist. We present the results of our 10 year experience of Vilnius University Hospital Santariskiu Klinikos. Patients and methodsRetrospective review was performed of the patients, operated on for rectal prolapse between 2005 and 2016. Patients were divided into two groups -internal recal prolapse (IRP) and complete rectal prolapse (CRP). Perioperative data between two groups were analysed. Statistical data analysis was carried out using the SPSS 20.0 software. To assess the difference between rectal prolapse groups of statistical methods the χ 2 test was used. Data were considered statistically significant at p < 0.05. Results 89 patients between 2005 and 2016 underwent surgical treatment for rectal prolapse at our department. IRP group included 52 (58,4%), CRP -37 (41,6%) patients. The male/female ratio was 1/6,4, the mean age was 58,3±15,2 years. Defecography was performed for 29 (32,6%)patients in IRP group and for 12 (13,5%) -in CRP group (p<0,001). 7 (7,9%) patients in CRP group had previous surgical procedure for RP while in IRP group there were none (p=0,02). The most common management of IRP included 6 strategies (n=25, 67,5% of group); of CRP -3 different procedures (n=38, 73,1% of group) (p=0,003). Mean hospital stay in IRP group was significantly (p=0,014) longer (9,78±4,6 days) than in CRP group (7,58±3,7 days). Mortality rate was 0 %. Mean follow-up (14 patients) was 20,93±17,21 months. ConclusionThere is no evidence-based consensus regarding treatment of rectal prolapse. Management of IRP covered a more diverse range of surgical options, including of open approach. Thus, hospital stay was longer, but no mortality occurred. Further follow-up for evaluation of long-term outcome is necessary. Key words: rectal prolapse, rectopexy, resection, laparoscopy 153Surgery for rectal prolapse -a single centre experience Įvadas Dėl vienos tiesiosios žarnos iškritimo gydymo strategijos nesutariama. Mes apžvelgėme tiesiosios žarnos iškritimo gydymą Vilniaus universiteto ligoninėje Santariškių klinikose. Pacientai ir metodaiRetrospektyviai tirti pacientai, operuoti dėl tiesiosios žarnos iškritimo 2005-2016 metais. Pacientai suskirstyti į dvi grupesviso storio iškritimo (CRP) ir vidinio iškritimo (IRP). Buvo palyginti perioperaciniai grupių duomenys. Duomenys apdoroti statistinio duomenų paketo SPSS 20.0 versija. Skirtumas tarp grupių lygintas remiantis chi kvadrato testu, vertintas kaip reikš-mingas, jei p vertė buvo < 0,05. Rezultatai Minėtu laikotarpiu operuoti 89 pacientai. Dėl vidinio iškritimo -52 (58,4 %), dėl viso storio iškritimo -37 (41,6 %). Vyrų ir moterų santykis buvo 1/6,4, vidutinis amžius -58,3 ± 15,2 metų. Defekografija atlikta 29 (32,6 %) IRP grupės ir 12 (13,5 %) -CRP grupės pacientams (p < 0,001). Septyni (7,9 %) CRP grupės pacientai praeityje buvo operuoti dėl tiesiosios žarnos iškritmo, o IRP grupėje anksčiau operuotų pacientų nebuvo (p=0,02). IRP grupės pacientai buvo operuoti šešiais būdais, o CRP -trimis būd...

show abstract

A systematic review and meta-analysis of conventional laparoscopic sacrocolpopexy versus robot-assisted laparoscopic sacrocolpopexy

Abstract: The clinical outcomes of prolapse surgery are similar with RALSC and LSC, but RALSC is less efficient in terms of cost and time.

Cited by 76 publications

References 35 publications

The future of robotic‐assisted laparoscopic gynaecologic surgery in Australia – A time and a place for everything

The future of robotic‐assisted laparoscopic gynaecologic surgery in Australia – A time and a place for everything

The incidence of transfusion and associated risk factors in pelvic reconstructive surgery

Tiesiosios žarnos iškritimo chirurginis gydymas – vieno centro patirtis

Contact Info

Product

Resources

About